Latest On Alector, Inc (ALEC):
About Alector, Inc (ALEC):
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies. The company was founded in 2013 and is headquartered in South San Francisco, California.
General
- Name Alector, Inc
- Symbol ALEC
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 171
- Fiscal Year EndDecember
- IPO Date2019-02-07
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.alector.com
Valuation
- Price/Sales (Trailing 12 Mt.) 68.96
- Price/Book (Most Recent Quarter) 5.57
- Enterprise Value Revenue 53.42
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.90
- Next Year EPS Estimate -$2.61
- Next Quarter EPS Estimate -$0.69
- Operating Margin -924%
- Return on Assets -27%
- Return on Equity -82%
- Revenue 21.1 million
- Earnings Per Share -$2.26
- Revenue Per Share $0.27
- Gross Profit -135771000
- Quarterly Earnings Growth -19.1%
Highlights
- Market Capitalization 1.43 billion
- EBITDA -80913000
- PE Ratio -4.49
- Analyst Target Price $31.88
- Book Value Per Share $3.37
Share Statistics
- Shares Outstanding 79.58 million
- Shares Float 56.59 million
- % Held by Insiders 1281%
- % Held by Institutions 78.94%
- Shares Short 5.41 million
- Shares Short Prior Month 5.05 million
- Short Ratio 9.62
- Short % of Float 12%
- Short % of Shares Outstanding 7%
Technicals
- Beta 1.04
- 52 Week High $34.89
- 52 Week Low $9.12
- 50 Day Moving Average 18.61
- 200 Day Moving Average 14.44
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Alector, Inc (ALEC) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Alector, Inc (ALEC) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $4.85 million | -$0.66 | -$0.65 | -1.93% |
2020-09-30 | 2020-11-10 | $N/A | -$0.67 | -$0.55 | -22.53% |
2020-06-30 | 2020-08-11 | $N/A | -$0.58 | -$0.50 | -14.99% |
2020-03-31 | 2020-05-13 | $7.17 million | -$0.53 | -$0.43 | -22.69% |
2019-12-31 | 2020-03-24 | $6 million | -$0.45 | -$0.44 | -1.69% |
2019-09-30 | 2019-11-12 | $2.7 million | -$0.47 | -$0.40 | -17.5% |
2019-06-30 | 2019-08-12 | $6.92 million | -$0.36 | -$0.32 | -12.5% |
2019-03-31 | 2019-05-13 | $5.61 million | -$0.27 | -$0.32 | 14.29% |
2018-12-31 | 2019-03-26 | $9.15 million | -$0.27 | -$0.27 | -0.37% |
Alector, Inc (ALEC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Alector, Inc (ALEC) Chart:
Alector, Inc (ALEC) News:
Below you will find a list of latest news for Alector, Inc (ALEC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Alector, Inc (ALEC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-04-19 | 2.5 | 0 | CALL | 0 | 0 | 197.18 | TRUE | 0 | 0 |
2024-04-19 | 5 | 1 | CALL | 0 | 71 | 119.55 | TRUE | 0 | 0 |
2024-04-19 | 7.5 | 0.2 | CALL | 33 | 104 | 81.12 | FALSE | 0.2 | 0 |
2024-04-19 | 10 | 0.05 | CALL | 0 | 45 | 0 | FALSE | 0 | 0 |
2024-04-19 | 12.5 | 0.3 | CALL | 0 | 14 | 0 | FALSE | 0 | 0 |
2024-04-19 | 15 | 0.15 | CALL | 0 | 21 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 5 | 0.35 | PUT | 0 | 28 | 0 | FALSE | 0 | 0 |
2024-04-19 | 7.5 | 1.2 | PUT | 0 | 28 | 147.73 | TRUE | 0 | 0 |
2024-04-19 | 10 | 2.47 | PUT | 0 | 0 | 144.61 | TRUE | 0 | 0 |
2024-04-19 | 12.5 | 0 | PUT | 0 | 0 | 274.74 | TRUE | 0 | 0 |
2024-04-19 | 15 | 0 | PUT | 0 | 0 | 269.11 | TRUE | 0 | 0 |
2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 1044.54 | TRUE | 0 | 0 |
2024-05-17 | 5 | 0 | CALL | 0 | 0 | 214.58 | TRUE | 0 | 0 |
2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 161.28 | TRUE | 0 | 0 |
2024-05-17 | 10 | 0 | PUT | 0 | 0 | 89.24 | TRUE | 0 | 0 |
2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 117.64 | TRUE | 0 | 0 |
2024-07-19 | 2.5 | 6.13 | CALL | 0 | 5 | 186.19 | TRUE | 0 | 0 |
2024-07-19 | 5 | 2.71 | CALL | 0 | 6 | 69.94 | TRUE | 0 | 0 |
2024-07-19 | 7.5 | 0.46 | CALL | 0 | 177 | 71.39 | FALSE | 0 | 0 |
2024-07-19 | 10 | 0.35 | CALL | 0 | 55 | 83.05 | FALSE | 0 | 0 |
2024-07-19 | 12.5 | 0.23 | CALL | 0 | 30 | 0 | FALSE | 0 | 0 |
2024-07-19 | 15 | 0.19 | CALL | 0 | 39 | 0 | FALSE | 0 | 0 |
2024-07-19 | 2.5 | 0.23 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
2024-07-19 | 5 | 0.22 | PUT | 0 | 11 | 0 | FALSE | 0 | 0 |
2024-07-19 | 7.5 | 2.1 | PUT | 0 | 14 | 62.85 | TRUE | 0 | 0 |
2024-07-19 | 10 | 3.4 | PUT | 0 | 0 | 102.47 | TRUE | 0 | 0 |
2024-07-19 | 12.5 | 0 | PUT | 0 | 0 | 113.2 | TRUE | 0 | 0 |
2024-07-19 | 15 | 0 | PUT | 0 | 0 | 131.4 | TRUE | 0 | 0 |
2024-10-18 | 2.5 | 0 | CALL | 0 | 0 | 131.68 | TRUE | 0 | 0 |
2024-10-18 | 5 | 2.35 | CALL | 0 | 7 | 127.27 | TRUE | 0 | 0 |
2024-10-18 | 7.5 | 0 | CALL | 0 | 0 | 67.76 | FALSE | 0 | 0 |
2024-10-18 | 10 | 0.51 | CALL | 0 | 116 | 76.53 | FALSE | 0 | 0 |
2024-10-18 | 12.5 | 0 | CALL | 0 | 0 | 85.58 | FALSE | 0 | 0 |
2024-10-18 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 5 | 0 | PUT | 0 | 0 | 74.08 | FALSE | 0 | 0 |
2024-10-18 | 7.5 | 1.85 | PUT | 0 | 2 | 64.37 | TRUE | 0 | 0 |
2024-10-18 | 10 | 0 | PUT | 0 | 0 | 93.73 | TRUE | 0 | 0 |
2024-10-18 | 12.5 | 0 | PUT | 0 | 0 | 128.09 | TRUE | 0 | 0 |
2025-01-17 | 2.5 | 0 | CALL | 0 | 0 | 101.3 | TRUE | 0 | 0 |
2025-01-17 | 5 | 0 | CALL | 0 | 0 | 76.39 | TRUE | 0 | 0 |
2025-01-17 | 7.5 | 0 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2025-01-17 | 10 | 0 | CALL | 0 | 0 | 76.48 | FALSE | 0 | 0 |
2025-01-17 | 12.5 | 0 | CALL | 0 | 0 | 80.45 | FALSE | 0 | 0 |
2025-01-17 | 15 | 0 | CALL | 0 | 0 | 84.47 | FALSE | 0 | 0 |
2025-01-17 | 2.5 | 0 | PUT | 0 | 0 | 117.11 | FALSE | 0 | 0 |
2025-01-17 | 5 | 1 | PUT | 0 | 10 | 72.03 | FALSE | 0 | 0 |
2025-01-17 | 7.5 | 0 | PUT | 0 | 0 | 70.91 | TRUE | 0 | 0 |
2025-01-17 | 10 | 3.8 | PUT | 0 | 5 | 104.83 | TRUE | 0 | 0 |
2025-01-17 | 12.5 | 0 | PUT | 0 | 0 | 120.6 | TRUE | 0 | 0 |
2025-01-17 | 15 | 0 | PUT | 0 | 0 | 115.44 | TRUE | 0 | 0 |
Latest ALEC Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 100 | $7.83 |
Jun 13, 2022 7:59 PM EST | 56 | $7.83 |
Jun 13, 2022 7:59 PM EST | 52 | $7.83 |
Jun 13, 2022 7:59 PM EST | 80 | $7.83 |
Jun 13, 2022 7:59 PM EST | 11 | $7.83 |
Alector, Inc (ALEC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm |
2018-11-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1653087/000000000018034674/0000000000-18-034674-index.htm |
2018-12-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1653087/000000000018037148/0000000000-18-037148-index.htm |
2018-12-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1653087/000000000018038840/0000000000-18-038840-index.htm |
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000089924320017680/0000899243-20-017680-index.htm |
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm |
2019-02-20 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000130/0000947871-19-000130-index.htm |
2019-08-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000575/0000947871-19-000575-index.htm |
2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm |
2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm |
2019-12-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000979/0000947871-19-000979-index.htm |
2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2020-01-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000022/0000947871-20-000022-index.htm |
2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm |
2020-02-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000087/0000947871-20-000087-index.htm |
2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm |
2020-03-04 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000184/0000947871-20-000184-index.htm |
2020-03-24 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000254/0000947871-20-000254-index.htm |
2020-03-24 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000255/0000947871-20-000255-index.htm |
2020-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm |
2020-03-30 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000302/0000947871-20-000302-index.htm |
2020-03-30 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000303/0000947871-20-000303-index.htm |
2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm |
2020-04-09 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000369/0000947871-20-000369-index.htm |
2020-04-09 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000370/0000947871-20-000370-index.htm |
2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm |
2020-04-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000387/0000947871-20-000387-index.htm |
2020-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm |
2020-06-04 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000541/0000947871-20-000541-index.htm |
2020-07-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000614/0000947871-20-000614-index.htm |
2020-07-16 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000626/0000947871-20-000626-index.htm |
2018-10-12 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1653087/000095012318009894/0000950123-18-009894-index.htm |
2018-10-12 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1653087/000095012318009895/0000950123-18-009895-index.htm |
2018-11-16 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1653087/000095012318012133/0000950123-18-012133-index.htm |
2018-11-16 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1653087/000095012318012135/0000950123-18-012135-index.htm |
2018-12-17 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1653087/000095012318012426/0000950123-18-012426-index.htm |
2019-12-02 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1653087/000095012319011700/0000950123-19-011700-index.htm |
2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1653087/000110465919008620/0001104659-19-008620-index.htm |
2019-01-07 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1653087/000119312519003772/0001193125-19-003772-index.htm |
2019-01-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1653087/000119312519003779/0001193125-19-003779-index.htm |
2019-01-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1653087/000119312519003784/0001193125-19-003784-index.htm |
2019-01-29 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1653087/000119312519019648/0001193125-19-019648-index.htm |
2019-01-31 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1653087/000119312519024072/0001193125-19-024072-index.htm |
2019-02-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1653087/000119312519026990/0001193125-19-026990-index.htm |
2019-02-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1653087/000119312519026991/0001193125-19-026991-index.htm |
2019-02-06 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1653087/000119312519029514/0001193125-19-029514-index.htm |
2019-02-06 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1653087/000119312519029585/0001193125-19-029585-index.htm |
2019-02-07 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1653087/000119312519030566/0001193125-19-030566-index.htm |
2019-02-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1653087/000119312519030597/0001193125-19-030597-index.htm |
2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000119312519033930/0001193125-19-033930-index.htm |
2019-03-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1653087/000119312519088558/0001193125-19-088558-index.htm |
2019-03-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1653087/000119312519088567/0001193125-19-088567-index.htm |
2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000119312519172525/0001193125-19-172525-index.htm |
2020-01-27 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1653087/000119312520015336/0001193125-20-015336-index.htm |
2020-01-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1653087/000119312520015374/0001193125-20-015374-index.htm |
2020-01-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1653087/000119312520015381/0001193125-20-015381-index.htm |
2020-01-29 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1653087/000119312520017882/0001193125-20-017882-index.htm |
2020-01-29 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1653087/000119312520018822/0001193125-20-018822-index.htm |
2020-01-30 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1653087/000119312520019151/0001193125-20-019151-index.htm |
2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000119312520024249/0001193125-20-024249-index.htm |
2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1653087/000119312520033331/0001193125-20-033331-index.htm |
2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000119312520067324/0001193125-20-067324-index.htm |
2020-05-13 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1653087/000119312520141645/0001193125-20-141645-index.htm |
2020-05-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1653087/000119312520141685/0001193125-20-141685-index.htm |
2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000119312520141724/0001193125-20-141724-index.htm |
2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000119312520143955/0001193125-20-143955-index.htm |
2019-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1653087/000119380519000158/0001193805-19-000158-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007883/0001209191-19-007883-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007884/0001209191-19-007884-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007885/0001209191-19-007885-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007886/0001209191-19-007886-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007887/0001209191-19-007887-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007889/0001209191-19-007889-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007890/0001209191-19-007890-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007892/0001209191-19-007892-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007894/0001209191-19-007894-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007896/0001209191-19-007896-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007898/0001209191-19-007898-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007925/0001209191-19-007925-index.htm |
2019-02-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119007926/0001209191-19-007926-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009113/0001209191-19-009113-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009114/0001209191-19-009114-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009119/0001209191-19-009119-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009780/0001209191-19-009780-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009784/0001209191-19-009784-index.htm |
2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119029727/0001209191-19-029727-index.htm |
2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119029732/0001209191-19-029732-index.htm |
2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119029734/0001209191-19-029734-index.htm |
2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119029736/0001209191-19-029736-index.htm |
2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119029740/0001209191-19-029740-index.htm |
2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119029743/0001209191-19-029743-index.htm |
2019-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119045559/0001209191-19-045559-index.htm |
2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119045564/0001209191-19-045564-index.htm |
2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119046647/0001209191-19-046647-index.htm |
2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm |
2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119046985/0001209191-19-046985-index.htm |
2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050106/0001209191-19-050106-index.htm |
2019-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm |
2019-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm |
2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119053486/0001209191-19-053486-index.htm |
2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119055820/0001209191-19-055820-index.htm |
2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119055823/0001209191-19-055823-index.htm |
2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119055826/0001209191-19-055826-index.htm |
2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119055827/0001209191-19-055827-index.htm |
2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119055829/0001209191-19-055829-index.htm |
2019-11-19 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119057197/0001209191-19-057197-index.htm |
2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119057201/0001209191-19-057201-index.htm |
2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119057203/0001209191-19-057203-index.htm |
2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059299/0001209191-19-059299-index.htm |
2019-12-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm |
2019-12-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060223/0001209191-19-060223-index.htm |
2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm |
2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm |
2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060931/0001209191-19-060931-index.htm |
2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120004048/0001209191-20-004048-index.htm |
2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm |
2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005031/0001209191-20-005031-index.htm |
2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm |
2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm |
2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005056/0001209191-20-005056-index.htm |
2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm |
2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120006112/0001209191-20-006112-index.htm |
2020-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm |
2020-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007210/0001209191-20-007210-index.htm |
2020-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm |
2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm |
2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120008414/0001209191-20-008414-index.htm |
2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm |
2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm |
2020-03-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120021014/0001209191-20-021014-index.htm |
2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120021016/0001209191-20-021016-index.htm |
2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120024871/0001209191-20-024871-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120028986/0001209191-20-028986-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120028991/0001209191-20-028991-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120028993/0001209191-20-028993-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120028995/0001209191-20-028995-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120028997/0001209191-20-028997-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120029004/0001209191-20-029004-index.htm |
2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm |
2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm |
2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm |
2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm |
2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120053597/0001209191-20-053597-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120053599/0001209191-20-053599-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120053605/0001209191-20-053605-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120053606/0001209191-20-053606-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120053612/0001209191-20-053612-index.htm |
2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1653087/000120919120053614/0001209191-20-053614-index.htm |
2019-02-04 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1653087/000135445719000055/0001354457-19-000055-index.htm |
2019-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019009355/0001564590-19-009355-index.htm |
2019-03-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1653087/000156459019009358/0001564590-19-009358-index.htm |
2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019018836/0001564590-19-018836-index.htm |
2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1653087/000156459019018837/0001564590-19-018837-index.htm |
2019-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019019627/0001564590-19-019627-index.htm |
2019-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019031472/0001564590-19-031472-index.htm |
2019-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019031482/0001564590-19-031482-index.htm |
2019-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1653087/000156459019031488/0001564590-19-031488-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019042915/0001564590-19-042915-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1653087/000156459019042920/0001564590-19-042920-index.htm |
2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019045755/0001564590-19-045755-index.htm |
2019-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459019045969/0001564590-19-045969-index.htm |
2020-03-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459020012509/0001564590-20-012509-index.htm |
2020-03-24 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1653087/000156459020012520/0001564590-20-012520-index.htm |
2020-03-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1653087/000156459020012557/0001564590-20-012557-index.htm |
2020-03-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1653087/000156459020014173/0001564590-20-014173-index.htm |
2020-03-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1653087/000156459020014205/0001564590-20-014205-index.htm |
2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459020024870/0001564590-20-024870-index.htm |
2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1653087/000156459020025043/0001564590-20-025043-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459020039316/0001564590-20-039316-index.htm |
2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1653087/000156459020039319/0001564590-20-039319-index.htm |
2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1653087/000156459020045922/0001564590-20-045922-index.htm |
2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1653087/000162363220000229/0001623632-20-000229-index.htm |
2015-09-16 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1653087/000165308715000001/0001653087-15-000001-index.htm |
2019-02-06 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1653087/999999999519000107/9999999995-19-000107-index.htm |
2020-01-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1653087/999999999520000190/9999999995-20-000190-index.htm |
2019-02-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1653087/999999999719000119/9999999997-19-000119-index.htm |
Alector, Inc (ALEC) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alector, Inc (ALEC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1281%Institutional Ownership: 7894%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-03-02 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 38,808.00 | 26.00 | 1,009,008.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm |
2019-02-11 | CARL L GORDON | Director | Buy | 157,939.00 | 19.00 | 3,000,841.00 | 10,434,976.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm |
2019-02-11 | ORBIMED ADVISORS LLC | Director | Buy | 157,939.00 | 19.00 | 3,000,841.00 | 10,434,976.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm |
2020-02-07 | Calvin Yu | Vice President, Finance | Sell | 24,033.00 | 35.02 | 841,635.66 | 110,686.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm |
2020-06-03 | Calvin Yu | Vice President, Finance | Sell | 300.00 | 32.02 | 9,606.00 | 110,686.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm |
2020-06-03 | Calvin Yu | Vice President, Finance | Sell | 1,043.00 | 31.04 | 32,374.72 | 110,986.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm |
2020-02-06 | Calvin Yu | Vice President, Finance | Sell | 2,621.00 | 35.00 | 91,735.00 | 124,494.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm |
2020-02-04 | Calvin Yu | Vice President, Finance | Sell | 63,541.00 | 30.04 | 1,908,771.64 | 125,294.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm |
2020-02-06 | Calvin Yu | Vice President, Finance | Buy | 1,096.00 | 8.16 | 8,943.36 | 126,390.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm |
2020-02-06 | Calvin Yu | Vice President, Finance | Buy | 725.00 | 10.14 | 7,351.50 | 127,115.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm |
2020-02-07 | Calvin Yu | Vice President, Finance | Buy | 2,825.00 | 8.16 | 23,052.00 | 127,319.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm |
2020-06-23 | Polaris Venture Management Co. VI, L.L.C. | 10% Share Holder | Sell | 4,377.00 | 31.54 | 138,062.84 | 12,853,817.00 | https://www.sec.gov/Archives/edgar/data/1653087/000089924320017680/0000899243-20-017680-index.htm |
2020-06-23 | TERRANCE MCGUIRE | Director | Sell | 4,377.00 | 31.54 | 138,062.84 | 12,853,817.00 | https://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm |
2020-02-07 | Calvin Yu | Vice President, Finance | Buy | 7,400.00 | 10.14 | 75,036.00 | 134,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm |
2019-12-03 | Calvin Yu | Vice President, Finance | Sell | 1,315.00 | 18.31 | 24,077.65 | 175,294.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059299/0001209191-19-059299-index.htm |
2020-02-04 | Calvin Yu | Vice President, Finance | Buy | 13,541.00 | 8.16 | 110,494.56 | 188,835.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm |
2020-04-16 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 15,086.00 | 23.53 | 354,973.58 | 1,906,718.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm |
2020-04-14 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 5,636.00 | 23.52 | 132,558.72 | 1,921,804.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm |
2020-04-09 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 69,893.00 | 23.79 | 1,662,754.47 | 1,927,440.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm |
2020-04-08 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 20,041.00 | 23.65 | 473,969.65 | 1,997,333.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm |
2020-04-07 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 2,224.00 | 23.10 | 51,374.40 | 2,017,374.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm |
2020-03-31 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 60,645.00 | 24.50 | 1,485,802.50 | 2,019,598.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm |
2019-02-11 | CARL L GORDON | Director | Buy | 203,200.00 | 19.00 | 3,860,800.00 | 203,200.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm |
2019-02-11 | ORBIMED ADVISORS LLC | Director | Buy | 203,200.00 | 19.00 | 3,860,800.00 | 203,200.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm |
2020-03-25 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 13,684.00 | 24.66 | 337,447.44 | 2,080,243.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm |
2020-03-24 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 16,409.00 | 24.45 | 401,200.05 | 2,093,927.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm |
2020-03-23 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 3,541.00 | 26.05 | 92,243.05 | 2,110,336.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm |
2020-03-02 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 445,086.00 | 26.00 | 11,572,236.00 | 2,113,877.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm |
2020-07-15 | Robert Paul | Chief Medical Officer | Sell | 378.00 | 23.58 | 8,913.24 | 213,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm |
2020-07-15 | Robert Paul | Chief Medical Officer | Sell | 9,622.00 | 22.94 | 220,728.68 | 214,097.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm |
2020-06-15 | Robert Paul | Chief Medical Officer | Sell | 3,909.00 | 29.90 | 116,879.10 | 223,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm |
2020-06-15 | Robert Paul | Chief Medical Officer | Sell | 6,091.00 | 29.43 | 179,258.13 | 227,628.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm |
2020-05-15 | Robert Paul | Chief Medical Officer | Sell | 2,104.00 | 27.78 | 58,449.12 | 233,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm |
2020-05-15 | Robert Paul | Chief Medical Officer | Sell | 5,996.00 | 27.00 | 161,892.00 | 235,823.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm |
2020-05-15 | Robert Paul | Chief Medical Officer | Sell | 1,900.00 | 26.15 | 49,685.00 | 241,819.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm |
2020-04-15 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 22.27 | 222,700.00 | 243,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120024871/0001209191-20-024871-index.htm |
2019-02-11 | CARL L GORDON | Director | Buy | 50,561.00 | 19.00 | 960,659.00 | 2,455,853.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm |
2019-02-11 | ORBIMED ADVISORS LLC | Director | Buy | 50,561.00 | 19.00 | 960,659.00 | 2,455,853.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm |
2020-03-13 | Robert Paul | Chief Medical Officer | Sell | 176.00 | 24.46 | 4,304.96 | 253,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm |
2020-03-13 | Robert Paul | Chief Medical Officer | Sell | 5,459.00 | 23.49 | 128,231.91 | 253,895.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm |
2020-01-09 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 91,818.00 | 19.50 | 1,790,451.00 | 2,558,963.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm |
2020-03-13 | Robert Paul | Chief Medical Officer | Sell | 2,884.00 | 22.47 | 64,803.48 | 259,354.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm |
2020-03-13 | Robert Paul | Chief Medical Officer | Sell | 1,481.00 | 21.57 | 31,945.17 | 262,238.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm |
2020-02-14 | Robert Paul | Chief Medical Officer | Sell | 7,000.00 | 29.74 | 208,180.00 | 263,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm |
2019-12-26 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 2,325.00 | 18.60 | 43,245.00 | 2,650,781.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-24 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 15,476.00 | 19.59 | 303,174.84 | 2,653,106.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-23 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 20,350.00 | 19.82 | 403,337.00 | 2,668,582.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-20 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 73,879.00 | 19.66 | 1,452,461.14 | 2,688,932.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2020-02-14 | Robert Paul | Chief Medical Officer | Sell | 3,000.00 | 29.07 | 87,210.00 | 270,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm |
2020-01-15 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 18.67 | 186,700.00 | 273,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120004048/0001209191-20-004048-index.htm |
2020-01-23 | Robert Paul | Chief Medical Officer | Sell | 599.00 | 25.22 | 15,106.78 | 273,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm |
2020-01-30 | Robert Paul | Chief Medical Officer | Sell | 8,000.00 | 28.00 | 224,000.00 | 273,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm |
2020-02-05 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 32.10 | 321,000.00 | 273,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm |
2020-01-23 | Robert Paul | Chief Medical Officer | Sell | 5,401.00 | 24.22 | 130,812.22 | 274,318.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm |
2019-12-17 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 205,793.00 | 18.52 | 3,811,286.36 | 2,762,811.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm |
2020-01-23 | Robert Paul | Chief Medical Officer | Buy | 6,000.00 | 8.16 | 48,960.00 | 279,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm |
2020-01-30 | Robert Paul | Chief Medical Officer | Buy | 8,000.00 | 8.16 | 65,280.00 | 281,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm |
2020-02-05 | Robert Paul | Chief Medical Officer | Buy | 10,000.00 | 8.16 | 81,600.00 | 283,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm |
2019-12-13 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 20.03 | 200,300.00 | 283,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060931/0001209191-19-060931-index.htm |
2019-11-15 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 15.93 | 159,300.00 | 293,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119057201/0001209191-19-057201-index.htm |
2019-08-07 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 157,636.00 | 17.90 | 2,821,684.40 | 2,968,604.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm |
2019-10-15 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 14.68 | 146,800.00 | 301,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119053486/0001209191-19-053486-index.htm |
2019-09-16 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 19.08 | 190,800.00 | 311,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050106/0001209191-19-050106-index.htm |
2019-09-20 | Robert Paul | Chief Medical Officer | Sell | 4,000.00 | 20.00 | 80,000.00 | 311,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm |
2019-09-20 | Robert Paul | Chief Medical Officer | Buy | 4,000.00 | 8.16 | 32,640.00 | 315,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm |
2019-08-20 | Robert Paul | Chief Medical Officer | Sell | 916.00 | 16.00 | 14,656.00 | 321,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm |
2019-08-19 | Robert Paul | Chief Medical Officer | Sell | 1,084.00 | 16.00 | 17,344.00 | 322,635.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm |
2019-08-15 | Robert Paul | Chief Medical Officer | Sell | 10,000.00 | 14.19 | 141,900.00 | 323,719.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119046647/0001209191-19-046647-index.htm |
2020-01-09 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 1,392.00 | 19.50 | 27,144.00 | 38,808.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm |
2019-12-26 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 1,200.00 | 18.60 | 22,320.00 | 40,200.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-24 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 8,000.00 | 19.59 | 156,720.00 | 41,400.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2020-02-03 | David M. Wehner | Director | Buy | 20,000.00 | 25.00 | 500,000.00 | 44,621.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120006112/0001209191-20-006112-index.htm |
2020-05-15 | Robert King | Chief Development Officer | Sell | 3,003.00 | 27.78 | 83,423.34 | 477,317.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm |
2020-05-15 | Robert King | Chief Development Officer | Sell | 8,632.00 | 27.02 | 233,236.64 | 480,320.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm |
2020-05-15 | Robert King | Chief Development Officer | Sell | 3,365.00 | 26.24 | 88,297.60 | 488,952.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm |
2020-02-14 | Robert King | Chief Development Officer | Sell | 10,332.00 | 29.77 | 307,583.64 | 492,317.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm |
2019-12-23 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 10,400.00 | 19.82 | 206,128.00 | 49,400.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2020-02-14 | Robert King | Chief Development Officer | Sell | 4,668.00 | 29.09 | 135,792.12 | 502,649.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm |
2020-01-22 | Robert King | Chief Development Officer | Sell | 3.00 | 22.01 | 66.03 | 507,317.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm |
2020-01-21 | Robert King | Chief Development Officer | Sell | 14,997.00 | 22.01 | 330,083.97 | 507,320.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm |
2019-11-15 | Robert King | Chief Development Officer | Sell | 7,500.00 | 15.92 | 119,400.00 | 522,317.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119057203/0001209191-19-057203-index.htm |
2019-08-19 | Robert King | Chief Development Officer | Sell | 7,500.00 | 15.00 | 112,500.00 | 529,817.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119046985/0001209191-19-046985-index.htm |
2020-02-07 | Sabah Oney | Chief Business Officer | Sell | 19,900.00 | 35.03 | 697,097.00 | 573,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120008414/0001209191-20-008414-index.htm |
2020-02-06 | Sabah Oney | Chief Business Officer | Sell | 100.00 | 35.00 | 3,500.00 | 593,818.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm |
2019-09-20 | Sabah Oney | Chief Business Officer | Sell | 400.00 | 20.00 | 8,000.00 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm |
2019-12-05 | Sabah Oney | Chief Business Officer | Sell | 1,500.00 | 20.00 | 30,000.00 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm |
2019-12-06 | Sabah Oney | Chief Business Officer | Sell | 5,156.00 | 20.02 | 103,223.12 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm |
2019-12-09 | Sabah Oney | Chief Business Officer | Sell | 2,300.00 | 20.07 | 46,161.00 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm |
2019-12-10 | Sabah Oney | Chief Business Officer | Sell | 500.00 | 20.01 | 10,005.00 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm |
2019-12-12 | Sabah Oney | Chief Business Officer | Sell | 6,810.00 | 20.13 | 137,068.96 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm |
2020-01-23 | Sabah Oney | Chief Business Officer | Sell | 2,200.00 | 25.21 | 55,462.00 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm |
2020-01-27 | Sabah Oney | Chief Business Officer | Sell | 14,467.00 | 25.05 | 362,398.35 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm |
2020-02-04 | Sabah Oney | Chief Business Officer | Sell | 16,667.00 | 30.00 | 500,010.00 | 593,918.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm |
2019-09-20 | Sabah Oney | Chief Business Officer | Buy | 400.00 | 8.16 | 3,264.00 | 594,318.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm |
2019-12-10 | Sabah Oney | Chief Business Officer | Buy | 500.00 | 8.16 | 4,080.00 | 594,418.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm |
2019-12-05 | Sabah Oney | Chief Business Officer | Buy | 1,500.00 | 8.16 | 12,240.00 | 595,418.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm |
2020-04-16 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 47,097.00 | 23.53 | 1,108,192.41 | 5,955,674.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm |
2020-01-23 | Sabah Oney | Chief Business Officer | Buy | 2,200.00 | 8.16 | 17,952.00 | 596,118.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm |
2019-12-09 | Sabah Oney | Chief Business Officer | Buy | 2,300.00 | 8.16 | 18,768.00 | 596,218.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm |
2019-12-20 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 37,900.00 | 19.66 | 745,114.00 | 59,800.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-06 | Sabah Oney | Chief Business Officer | Buy | 5,156.00 | 8.16 | 42,072.96 | 599,074.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm |
2020-04-14 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 17,595.00 | 23.52 | 413,834.40 | 6,002,771.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm |
2019-12-12 | Sabah Oney | Chief Business Officer | Buy | 6,810.00 | 8.16 | 55,569.60 | 600,728.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm |
2020-04-09 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 218,208.00 | 23.79 | 5,191,168.32 | 6,020,366.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm |
2020-01-27 | Sabah Oney | Chief Business Officer | Buy | 14,467.00 | 8.16 | 118,050.72 | 608,385.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm |
2020-02-04 | Sabah Oney | Chief Business Officer | Buy | 16,667.00 | 8.16 | 136,002.72 | 610,585.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm |
2020-04-08 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 62,573.00 | 23.65 | 1,479,851.45 | 6,238,574.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm |
2020-04-07 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 6,946.00 | 23.10 | 160,452.60 | 6,301,147.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm |
2020-03-31 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 189,355.00 | 24.50 | 4,639,197.50 | 6,308,093.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm |
2020-03-25 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 42,727.00 | 24.66 | 1,053,647.82 | 6,497,448.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm |
2020-03-24 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 51,235.00 | 24.45 | 1,252,695.75 | 6,540,175.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm |
2020-03-23 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 11,057.00 | 26.05 | 288,034.85 | 6,591,410.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm |
2020-03-02 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 1,390,309.00 | 26.00 | 36,148,034.00 | 6,602,467.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm |
2020-01-09 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 286,787.00 | 19.50 | 5,592,346.50 | 7,992,776.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm |
2019-12-26 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 7,275.00 | 18.60 | 135,315.00 | 8,279,563.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-24 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 48,324.00 | 19.59 | 946,667.16 | 8,286,838.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-23 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 63,535.00 | 19.82 | 1,259,263.70 | 8,335,162.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-20 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 230,721.00 | 19.66 | 4,535,974.86 | 8,398,697.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm |
2019-12-17 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 642,807.00 | 18.52 | 11,904,785.64 | 8,629,418.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm |
2019-08-07 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 492,364.00 | 17.90 | 8,813,315.60 | 9,272,225.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm |
2019-12-17 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 105,500.00 | 18.52 | 1,953,860.00 | 97,700.00 | https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm |
2020-02-04 | RICHARD H SCHELLER | Director | Sell | 10,000.00 | 29.67 | 296,700.00 | 9,981.00 | https://www.sec.gov/Archives/edgar/data/1653087/000120919120007210/0001209191-20-007210-index.htm |